Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 45.93% is 335% above its 5-year average of 10.55%, near the high end of its 5-year range (-117.13%–45.93%).
As of the fiscal period ended Tuesday, June 30, 2026. 90.87% above its 12-month average of 24.06%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 45.93%.
RETURN ON EQUITY (ROE)
45.93%
RETURN ON EQUITY (ROE) AVG TTM
24.06%
RETURN ON EQUITY (ROE) AVG 3Y
-21.02%
RETURN ON EQUITY (ROE) AVG 5Y
10.55%
RETURN ON EQUITY (ROE) AVG 10Y
-2.75%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+90.87%
CURRENT VS 3Y AVG
+318.51%
CURRENT VS 5Y AVG
+335.29%
CURRENT VS 10Y AVG
+1768.01%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-29.15%
median of 341 covered companies
CURRENT VS SECTOR MEDIAN
+257.55%
vs the sector median at left
CareCloud, Inc.
Market Cap
$86.69M
Return on Equity (ROE)
45.93%
TTM Avg
24.06%
3Y Avg
-21.02%
5Y Avg
10.55%
Market Cap
$87.86M
Return on Equity (ROE)
-150.95%
TTM Avg
-77.89%
3Y Avg
-62.90%
5Y Avg
-47.80%
Market Cap
$84.75M
Return on Equity (ROE)
-85.65%
TTM Avg
-57.41%
3Y Avg
-45.73%
5Y Avg
-8.61%
Market Cap
$84.70M
Return on Equity (ROE)
N/A
TTM Avg
1.45%
3Y Avg
25.22%
5Y Avg
-14.52%
Market Cap
$83.96M
Return on Equity (ROE)
-50.80%
TTM Avg
-124.86%
3Y Avg
-88.30%
5Y Avg
-60.21%
Market Cap
$83.49M
Return on Equity (ROE)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$91.33M
Return on Equity (ROE)
N/A
TTM Avg
329.82%
3Y Avg
69.21%
5Y Avg
21.28%
Market Cap
$91.68M
Return on Equity (ROE)
-32.15%
TTM Avg
-60.32%
3Y Avg
-93.79%
5Y Avg
-79.41%
Market Cap
$81.22M
Return on Equity (ROE)
-114.06%
TTM Avg
-50.52%
3Y Avg
-45.18%
5Y Avg
-45.18%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CareCloud, Inc. (CCLD) | $86.69M | 45.93% | 24.06% | -21.02% | 10.55% |
| Cardiff Oncology, Inc. (CRDF)vs › | $87.86M | -150.95% | -77.89% | -62.90% | -47.80% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $84.75M | -85.65% | -57.41% | -45.73% | -8.61% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $84.70M | N/A | 1.45% | 25.22% | -14.52% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $83.96M | -50.80% | -124.86% | -88.30% | -60.21% |
| Conexeu Sciences Inc. (CNXU)vs › | $83.49M | N/A | N/A | N/A | N/A |
| electroCore, Inc. (ECOR)vs › | $91.33M | N/A | 329.82% | 69.21% | 21.28% |
| Equillium, Inc. (EQ)vs › | $91.68M | -32.15% | -60.32% | -93.79% | -79.41% |
| Citius Oncology, Inc. (CTOR)vs › | $81.22M | -114.06% | -50.52% | -45.18% | -45.18% |
| Biomea Fusion, Inc. (BMEA)vs › | $93.99M | -268.09% | -238.76% | -155.55% | -124.74% |
ROE
45.9%
ROA
8.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 45.93% |
| 2026-03-31 | 16.75% |
| 2025-12-31 | 18.15% |
| 2025-09-30 | 19.39% |
| 2025-06-30 | 20.09% |
| 2025-03-31 | 18.53% |
| 2024-12-31 | 15.77% |
| 2024-09-30 | -84.15% |
| 2024-06-30 | -104.08% |
| 2024-03-31 | -117.13% |
| 2023-12-31 | -116.68% |
| 2023-09-30 | -5.09% |
| 2023-06-30 | -0.72% |
| 2023-03-31 | 3.97% |
| 2022-12-31 | 5.34% |
| 2022-09-30 | 8.22% |
| 2022-06-30 | 8.67% |
| 2022-03-31 | 5.81% |
| 2021-12-31 | 2.90% |
| 2021-09-30 | -0.55% |
| 2021-06-30 | -3.79% |
| 2021-03-31 | -7.99% |
| 2020-12-31 | -8.70% |
| 2020-09-30 | -8.44% |
| 2020-06-30 | -8.94% |
| 2020-03-31 | -5.38% |
| 2019-12-31 | -2.04% |
| 2019-09-30 | -4.76% |
| 2019-06-30 | -10.10% |
| 2019-03-31 | -6.78% |
| 2018-12-31 | -5.50% |
| 2018-09-30 | -6.40% |
| 2018-06-30 | -3.07% |
| 2018-03-31 | -13.46% |
| 2017-12-31 | -27.48% |
| 2017-09-30 | -56.76% |
| 2017-06-30 | -87.92% |
| 2017-03-31 | -224.96% |
| 2016-12-31 | -124.48% |
| 2016-09-30 | -50.36% |
| 2016-06-30 | -46.80% |
| 2016-03-31 | -42.95% |
| 2015-12-31 | -31.48% |
| 2015-09-30 | -42.12% |
| 2015-06-30 | -55.66% |
| 2015-03-31 | -40.39% |
| 2014-12-31 | -31.49% |
| 2014-09-30 | -19.92% |
| 2013-12-31 | -98.15% |
| 2013-09-30 | -875.14% |
